Login / Signup

Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease.

Antonio LiguoriFrancesca D'AmbrosioCecilia NapodanoVanessa GentiliMaria Cristina GiustinianiMaurizio PompiliAntonio GriecoGianludovico RapacciniAndrea UrbaniAntonio GasbarriniUmberto BasileLuca Mielenull null
Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)
sFLCs could be a simple biomarker for stratification of cACLD in MASLD patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported